Who We Are
BeyondSpring is a Global, Clinical-Stage
Bio-pharmaceutical Company
Developing Innovative Immuno-Oncology Cancer Therapies with a Robust Pipeline from Internal Development and from Collaboration with University of Washington in De Novo Drug Discovery Using a Ubiquitination Platform.